Novato, CA, Feb. 26, 2014 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, today announced that Shalini Sharp, the company's Chief Financial Officer, will be presenting at the Cowen and Company 34th Annual Health Care Conference on March 5, 2014 at 11:20am ET at the Boston Marriott Copley Place.
Help employers find you! Check out all the jobs and post your resume.
